Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Keratin 79 marks a new group of cells that are key for creating and repairing the hair follicle's structure.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Pannexin 3 is important for bone formation and the development of bone cells.

Inactivating β-catenin is essential for chick retina regeneration.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Pannexin 3 helps skin and hair growth by controlling a protein called Epiprofin.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

PCOS causes hormonal imbalance, leading to symptoms like irregular periods and infertility.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Cellular senescence may play a role in ALS, and anti-senescence therapies could be a promising treatment.

OCT4 helps hair stem cells renew and fight aging, potentially aiding hair regrowth.

Hair follicle stem cells use specific chromatin changes to control their growth and differentiation.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.

Targeting cellular senescence may improve skin aging and disorders.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

ZO-1 helps hair follicle stem cells renew better by changing their structure.

Stem cells in the cornea show unexpected flexibility and have important implications for medicine.

Hair follicle dermal stem cells are key for regenerating parts of the hair follicle and determining hair type.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Hidradenitis suppurativa tunnels worsen the disease and often need surgery because current treatments are not very effective.